Clinical Trials

Showing 421 - 440 of 488 trials
Title Investigatorsort icon Disease(s)
A Pilot Study Assessing PET Probes to Detect Cancerous Tissue During Surgery for Recurrent Ovarian Cancer
[Protocol 13-017]
Chi, Dennis
  • Ovarian Cancer
A Phase II Study of Secondary Cytoreduction with and without HIPEC plus Postoperative Chemotherapy for Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Relapsed/Refractory
[Protocol 12-275]
Chi, Dennis
  • Ovarian Cancer
Electronic Patient-Reported Outcomes from Home in Patients Recovering from Major Gynecologic Cancer Surgery: Measuring Symptoms and Quality of Life
[Protocol 08-155]
Chi, Dennis
  • Cervical Cancer
  • Ovarian Cancer
  • Quality of Life
  • Uterine (Endometrial) Cancer
  • Vulvar Cancer
Molecular Characterization of Neuroblastic Tumors and Clinical Outcome
[Protocol 00-109]
Cheung, Nai-Kong
  • Neuroblastoma
A Phase II Clinical Trial of Trametinib plus GSK2141795 in Patients with Melanoma Containing a Normal BRAF Gene
[Protocol 13-258]
Chapman, Paul
  • Melanoma
A Phase II Study of Dabrafenib After Surgery in Patients with BRAF V600 Mutation-Positive Stage IIIC Melanoma
[Protocol 12-124]
Chapman, Paul
  • Melanoma
A Phase III Study of Vemurafenib in Patients with Surgically Removed BRAF-Mutant Melanoma Who Have a High Risk of Recurrence
[Protocol 12-166]
Chapman, Paul
  • Melanoma
A Phase II Study of LGX818 Given in a Pulsatile Schedule to Patients with Stage III or IV Melanoma with a BRAF Mutation
[Protocol 13-053]
Chapman, Paul
  • Melanoma
Molecular Mechanisms of Clinical Resistance to Anti-HER2 Therapy Among Patients with HER2-Amplified Breast Cancer
[Protocol 06-163]
Chandarlapaty, Sarat
  • Breast Cancer
A Phase I/II Clinical Trial of Temsirolimus plus Neratinib for Subjects with Metastatic HER2-Amplified or Triple-Negative Breast Cancer
[Protocol 10-005]
Chandarlapaty, Sarat
  • Breast Cancer
A Phase II Study of MPDL3280A in Patients with PD-L1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
[Protocol 13-084]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
A Phase II Study Comparing Three Months versus Two Years of Afatinib Therapy after Surgery for Patients with Stage I-III Non-Small Cell Lung Cancer
[Protocol 13-096]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
A Phase II Study of Neoadjuvant Pemetrexed Plus Cisplatin for Patients with Resectable Non-Squamous Non-Small Cell Lung Cancer with "Switch Chemotherapy Alternative" in Non-Responders (NEOSCAN)
[Protocol 11-106]
Chaft, Jamie
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I Study of Hepatic Arterial Infusion with Floxuridine, Dexamethasone, and Gemcitabine after Surgery for Liver Cholangiocarcinoma
[Protocol 13-148]
Cercek, Andrea
  • Hepatobiliary
    • Liver Cancer
Phase I Study of LOR-253 in Patients with Advanced or Metastatic Solid Tumors
[Protocol 09-021]
Cercek, Andrea
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and Stem Cell Transplantation in Patients with B-cell Non-Hodgkin's Lymphoma
[Protocol 06-150]
Castro-Malaspina, Hugo
  • Blood & Marrow Stem Cell Transplantation
    • Sibling and Unrelated Volunteer
  • Lymphoma
    • Non-Hodgkin's Lymphoma
Acupuncture for Chronic Lymphedema After Breast Cancer Treatment
[Protocol 12-210]
Cassileth, Barrie
  • Breast Cancer
  • Quality of Life
  • Survivorship
A Phase I Study of BVD-523 in Patients with Advanced Cancers
[Protocol 13-254]
Carvajal, Richard
  • Melanoma
  • Solid Tumors
A Phase I Study of Dasatinib and Ipilimumab for Patients with Advanced GIST or Other Sarcomas
[Protocol 12-083]
Carvajal, Richard
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of Trametinib with and without GSK2141795 in Patients with Advanced Uveal Melanoma
[Protocol 13-144]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye